NobleBlocks

Research indexJournal article

deVGen NV

Editor

PharmaDeals Review1 Jun 2003

NobleIDark:/48914/w1/20260523/69DAD547DOI10.3833/pdr.v2003i37.898

Paywalled

The full text is at the publisher

You can read the abstract here, or open it at the publisher.

Read at the publisher

Abstract

Pharmaceutical strategic business consultancy involved in partnering, licensing, acquisitions, divestments and new business start-ups. We assist in due diligence and write expert reports for investors. We are experts in business intelligence and markets

Discussion

Topics

More

Suggest a correction or report